Table 1.
Assessment | Screening | Baseline | Week 8 | Week 16 | Week 24 | Week 52 Final Visit |
---|---|---|---|---|---|---|
Informed Consent | X | |||||
Medical history | X | |||||
Physical exam | X | |||||
Randomization | X | |||||
Clinical Blood Pressure | X | X | X | X | X | |
24 hour ambulatory blood pressures | X | X | X | X | X | |
Fasting glucose/blood profile | X | |||||
2 hour glucose tolerance test | X | |||||
Physical Fitness | X | X | X | X | ||
Behavioural Measures | X | X | X | X | ||
Physiologic Measures | X | X | X | X | ||
Drug | X | X | X | |||
Placebo | X |